Sweden and Denmark halt use of Moderna vaccine in young people due to heart effects

Sweden and Denmark they suspended the application of the Modern laboratory young people “as a precaution”. The two countries have already vaccinated a large part of their population against the coronavirus, but they have decided to suspend it to study in depth the cardiac effects of this vaccine in the young population.

Sweden marked vaccination break with Moderna in under 30 years. Swedish Public Health Authority (FHM), in charge of the vaccination campaign, explained in a statement that “decided to discontinue the use of Moderna’s Spikevax vaccine, for all persons born after 1991, as a precautionary principle ”.

This decision is made “after signs of increased risk of side effects, such as inflammation of the myocardium and pericardium”. According to the agency, the risk is higher after the second dose and in men. However, “it’s minimal” and “a very rare side effect,” he said.

Covid-19: Another shipment with 1.6 million doses of Pfizer will arrive this week

For its part, Denmark has decided to stop vaccination with this laboratory in less than 18 years. He did so with a “precautionary principle” agreement. In this sense, the health authorities of the Nordic country have also clarified that they are using the BioNTech / Pfizer vaccine as the main option for people aged 12 to 17.

“In the preliminary data there is a suspicion of an increased risk of heart inflammation, when vaccinated with Moderna, ”the Danish health authority said in a statement.

In Argentina, Tuesday, October 5 the government made the decision to vaccinate with official Moderna boys and girls over 12 years old. For its part, ANMAT stressed that this vaccine was authorized in the United States, Canada, United Kingdom, Israel, the European Union and the World Health Organization. In addition, he stressed that “the parameters of safety, immunogenicity and efficacy” are “acceptable” to apply in the country.